Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Dovetail Genomics Unveils New Dovetail™ Hi-C Kit

Dovetail Genomics LLC
Posted on: 12 Jan 18
Dovetail Genomics Unveils New Dovetail™ Hi-C Kit Company lowers the price of its industry-leading Hi-C services and launches its first commercial kit, enabling researchers to generate best-in-class chromosome scale assemblies in-house

PR Newswire

SANTA CRUZ, Calif., Jan. 12, 2018

SANTA CRUZ, Calif., Jan. 12, 2018 /PRNewswire/ -- Dovetail Genomics™ LLC, the industry leader in the use of proximity ligation and advanced informatics for genomic solutions, today expanded its commitment to the research world to make best-in-class genome assemblies available to all. The new Dovetail Hi-C Kit, with cloud-based HiRise™ software for genome assembly, delivers the capabilities of the company's service offering in kit format for researchers who prefer a hands-on experience in their own labs. Additionally, Dovetail announced it has lowered its scaffolding service pricing, a result of efficiencies achieved by building and delivering hundreds of assemblies over the last few years.

The kit and software are available immediately and will be described in a Dovetail-hosted workshop on Tuesday, January 16 at the Plant & Animal Genome conference (PAG XXVI) in San Diego.

"We've used Dovetail's Hi-C service and HiRise software to assemble a wide range of animal and plant genomes into chromosomes, giving us a much richer perspective on the evolution of polyploid and other complex genomes. With the new Dovetail Hi-C kit and cloud-based HiRise, it will be easy to scale these studies so that every genome can—finally—be analyzed at the chromosome scale," said Dr. Daniel Rokhsar, Professor of Genetics, Genomics and Development at UC Berkeley; Eukaryote Super Program Head at the Joint Genome Institute; Visiting Professor of Molecular Genetics at the Okinawa Institute for Science and Technology; and, Dovetail Genomics Scientific Advisory Board Member.

Added Dovetail's CEO, Todd Dickinson, "Since launching our service, we have produced hundreds of chromosome-scale, reference-quality assemblies for our customers. But we have long been committed to making it possible for anyone to access the quality of a Dovetail assembly, and today's Hi-C kit and HiRise software launch represents a significant and gratifying milestone for our company. Leveraging our services experience, our team has created a robust, turn-key kit and software solution that brings industry-best genome assembly directly into researchers' own hands and makes it easier to conduct large-scale studies across a multitude of applications. Researchers now have the choice to bring the genome assembly process in-house and incorporate it into their own workflows, or they can continue to use our simple, streamlined services."

About Dovetail
Dovetail Genomics LLC is transforming genomics by making long-range information readily accessible to all. The company enables researchers and clinicians to solve complex problems involving de novo assembly, structural variation, microbiome analysis, cancer research, phasing analysis and more by providing them a more comprehensive view of the genome. Its proprietary in vitro proximity ligation approach and assembly algorithms simplify genomic discovery by integrating the highest quality long-range genomic information with next-gen sequencing output. Dovetail is based in Santa Cruz, California. For more information on Dovetail, its technology, and service offerings, visit Follow Dovetail on Twitter @DTGenomics.


View original content:

SOURCE Dovetail Genomics LLC

PR Newswire

Last updated on: 12/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.